Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/FORESEE-PHARMACEUTICALS-C-45304233/news/Foresee-Pharmaceuticals-Announces-First-Patient-Dosed-in-the-Casppian-Phase-3-Clinical-Trial-of-Leu-45058315/?utm_source=whatsapp&utm_medium=social&utm_campaign=share